Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Journal of Medicinal Chemistry
|
January 18, 2012
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors
Kevin X Chen, Charles A Lesburg, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase
Kevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitor
Qingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 16, 2011
I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles
Gopinadhan N Anilkumar, Charles A Lesburg, Oleg Selyutin, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor
Ashok Arasappan, Frank Bennett, Stephane L Bogen, et al.
Journal of Medicinal Chemistry
|
September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
Journal of Medicinal Chemistry
|
September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Journal of Medicinal Chemistry
|
January 18, 2012
A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors
Kevin X Chen, Charles A Lesburg, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase
Kevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitor
Qingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 16, 2011
I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles
Gopinadhan N Anilkumar, Charles A Lesburg, Oleg Selyutin, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor
Ashok Arasappan, Frank Bennett, Stephane L Bogen, et al.
Journal of Medicinal Chemistry
|
September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
Journal of Medicinal Chemistry
|
September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Page
of 4